Washington, DC, April 6, 2016—At a major gathering of leaders in the tuberculosis field, held in Washington DC, Wave 80 founder and Board of Directors chairman Dr. Daniel Laser was joined by Palu [...]
Liquid micropiston-based sample prep technology meet emerging needs around sequencing multi-drug resistant strains
Strong NGO support cited for system's capacity for multiplexing and exceptionally high performance sample prep module
Dr. Laura Mazzola, Wave 80’s Senior Vice President of Global Initiatives, co-authors analysis of impact and opportunities for new diagnostics technologies.
Talk will highlight evolving challenges and opportunities in global health
With NIH support, initiative seeks to develop innovative new molecular diagnostics tools for guiding vaccine development and antiretroviral therapy
